Glycogen storage disease type IV: Difference between revisions
No edit summary |
No edit summary |
||
Line 17: | Line 17: | ||
{{SI}} | {{SI}} | ||
{{CMG}} | {{CMG}} | ||
'''''Synonyms and keywords:''''' Glycogenosis type IV , Andersen's disease , glycogen branching enzyme deficiency (GBED , polyglucosan body disease, amylopectinosis | '''''Synonyms and keywords:''''' Glycogenosis type IV , Andersen's disease , glycogen branching enzyme deficiency (GBED , polyglucosan body disease, amylopectinosis | ||
Revision as of 06:48, 29 July 2012
Glycogen storage disease type IV | ||
Glycogen | ||
ICD-10 | E74.0 | |
ICD-9 | 271.0 | |
OMIM | 232500 | |
DiseasesDB | 5303 | |
MeSH | C16.320.565.202.449.540 |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Glycogenosis type IV , Andersen's disease , glycogen branching enzyme deficiency (GBED , polyglucosan body disease, amylopectinosis
Overview
Glycogen storage disease type IV is a very rare hereditary metabolic disorder.
Pathophysiology
It is a result of the absence of the glycogen branching enzyme amylo-1,4-1,6 transglucosidase, which is critical in the production of glycogen. This leads to very long unbranched glucose chains being stored in glycogen. The long unbranched molecules (known as amylopectin) have a low solubility which leads to glycogen precipitation in the liver. These deposits subsequently build up in the body tissue, especially the heart and liver.
Natural History , Complications and Prognosis
The end result is liver failure and eventual death occurring in the first year of life.